6681 Stock Overview
Develops medical-grade digital therapy (DTx) products for cognitive impairment. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
BrainAurora Medical Technology Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$6.21 |
| 52 Week High | HK$7.81 |
| 52 Week Low | HK$3.13 |
| Beta | 0 |
| 1 Month Change | -9.74% |
| 3 Month Change | 72.98% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 86.49% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6681 | HK Healthcare Services | HK Market | |
|---|---|---|---|
| 7D | 11.1% | 15.2% | 8.2% |
| 1Y | n/a | 18.8% | 18.5% |
Return vs Industry: Insufficient data to determine how 6681 performed against the Hong Kong Healthcare Services industry.
Return vs Market: Insufficient data to determine how 6681 performed against the Hong Kong Market.
Price Volatility
| 6681 volatility | |
|---|---|
| 6681 Average Weekly Movement | 10.9% |
| Healthcare Services Industry Average Movement | 14.4% |
| Market Average Movement | 7.9% |
| 10% most volatile stocks in HK Market | 15.1% |
| 10% least volatile stocks in HK Market | 4.2% |
Stable Share Price: 6681 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: Insufficient data to determine 6681's volatility change over the past year.
Community vs My Fair Value
Select a narrative for quick price alerts from the community, or create your own.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 159 | Xiaoyi Wang | 66nao.cn |
BrainAurora Medical Technology Limited develops medical-grade digital therapy (DTx) products for cognitive impairment. The company offers the evaluation and intervention of cognitive impairments to treat vascular diseases, neurodegenerative diseases, psychological disorders, and child development deficiencies. It develops the Brain Function Information Management Platform software system, an evidence-based, medical-grade DTx product; Cognitive Ability Testing software; the Cognitive Ability Supplemental Screening and Assessment software; and the Dyslexia Supplemental Screening and Assessment software.
BrainAurora Medical Technology Limited Fundamentals Summary
| 6681 fundamental statistics | |
|---|---|
| Market cap | HK$7.86b |
| Earnings (TTM) | -HK$210.30m |
| Revenue (TTM) | HK$129.73m |
60.6x
P/S Ratio-37.4x
P/E RatioIs 6681 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6681 income statement (TTM) | |
|---|---|
| Revenue | CN¥122.31m |
| Cost of Revenue | CN¥68.30m |
| Gross Profit | CN¥54.01m |
| Other Expenses | CN¥252.30m |
| Earnings | -CN¥198.28m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.16 |
| Gross Margin | 44.16% |
| Net Profit Margin | -162.11% |
| Debt/Equity Ratio | -140.7% |
How did 6681 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/14 06:34 |
| End of Day Share Price | 2025/04/14 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
BrainAurora Medical Technology Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.